Innovative veterinary medicine for better animal health
Through in-house research and pharmaceutical development, a growing product portfolio, and strong partnerships, Intervacc develops and provides veterinary vaccines and medicines that address key needs in animal health.
LATEST PRESS RELEASE: Intervacc to present at upcoming International Healthcare Conference»
LATEST REPORT:
Quarterly report Apr–Jun 2026
»
Our veterinary vaccines and medicines
Strangvac®
Strangvac® is our proprietary modern vaccine against strangles, a highly contagious and serious equine disease caused by the bacterium Streptococcus equi.Read more »
PiggivacTM
Development is underway of an innovative vaccine against infections caused by the bacterium Streptococcus suis – one of the most common causes of serious illness and mortality in pigs.Read more »
The product portfolio
In addition to our proprietary vaccine Strangvac®, we sell veterinary products for companion and farm animals in the Scandinavian markets. Read more »
FROM SCIENCE TO VETERINARY BENEFIT
Intervacc is a Swedish growth company in veterinary medicine
CEO PRESENTS
CURRENT PRESS RELEASES
IN THE CALENDAR
